New Key Statistics Module, Z-Score and F-Score
NAS:SRPT Key Ratios
Market Cap $ M | 11,019.63 |
Enterprise Value $ M | 11,576.05 |
P/E(ttm) | 74.91 |
PE Ratio without NRI | 70.73 |
Forward PE Ratio | 10.48 |
Price/Book | 9.02 |
Price/Sales | 7.07 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,640.00 |
EPS (TTM) $ | 1.54 |
Beneish M-Score | -1.2 |
10-y EBITDA Growth Rate % | -7.80 |
5-y EBITDA Growth Rate % | 3.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 77.93 |
EV-to-EBITDA | 61.84 |
PEG | 22.82 |
Shares Outstanding M | 95.52 |
Net Margin (%) | 7.43 |
Operating Margin % | 4.94 |
Pre-tax Margin (%) | 7.89 |
Quick Ratio | 3.03 |
Current Ratio | 3.84 |
ROA % (ttm) | 3.66 |
ROE % (ttm) | 12.48 |
ROIC % (ttm) | 4.93 |
Dividend Yield % | -- |
Altman Z-Score | 2.43 |
SRPT Number of Guru Trades
SRPT Volume of Guru Trades
Gurus Latest Trades with NAS:SRPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SRPT is held by these investors
Total 3
Sarepta Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SRPT
Total 0- 1